Thus, we conclude that the increased expression of BDNF-AS mediates both the direct anti-tumor effects of propofol on GSCs as well as the indirect effects of inhibiting the pro-tumorigenic crosstalk of GSCs with microglia via the transfer of BDNF-AS by EVs. The gene discussed is BDNF; the disease is neoplasm.